The Ensign Group (ENSG) Expected to Announce Quarterly Earnings on Wednesday

The Ensign Group (NASDAQ:ENSG) is projected to post its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $1.75 per share for the quarter. The Ensign Group has set its FY 2025 guidance at 6.480-6.540 EPS. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 12:00 AM ET.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings results on Monday, November 3rd. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.59 by $0.05. The business had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.28 billion. The Ensign Group had a net margin of 6.80% and a return on equity of 16.77%. The company’s revenue was up 19.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.39 EPS. On average, analysts expect The Ensign Group to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

The Ensign Group Stock Performance

Shares of NASDAQ:ENSG opened at $171.99 on Wednesday. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average price of $178.30 and a 200-day moving average price of $172.00. The company has a market cap of $9.96 billion, a price-to-earnings ratio of 30.77, a price-to-earnings-growth ratio of 1.85 and a beta of 0.86. The Ensign Group has a 12 month low of $118.73 and a 12 month high of $193.99.

The Ensign Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, January 31st. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Wednesday, December 31st. This is a positive change from The Ensign Group’s previous quarterly dividend of $0.06. The Ensign Group’s dividend payout ratio is currently 4.65%.

Wall Street Analyst Weigh In

Several brokerages have commented on ENSG. Stephens upped their price objective on shares of The Ensign Group from $185.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Weiss Ratings reissued a “buy (b)” rating on shares of The Ensign Group in a research note on Thursday, January 22nd. Truist Financial lifted their price objective on The Ensign Group from $190.00 to $200.00 and gave the company a “hold” rating in a research report on Monday, November 10th. Royal Bank Of Canada reiterated an “outperform” rating and set a $206.00 target price (up previously from $177.00) on shares of The Ensign Group in a report on Friday, November 14th. Finally, UBS Group restated a “buy” rating and issued a $220.00 target price (up previously from $205.00) on shares of The Ensign Group in a research note on Wednesday, November 5th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $196.40.

Insiders Place Their Bets

In other news, Director Daren Shaw sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $178.57, for a total transaction of $178,570.00. Following the sale, the director owned 24,126 shares of the company’s stock, valued at $4,308,179.82. This trade represents a 3.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Beverly B. Wittekind sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $180.00, for a total transaction of $360,000.00. Following the completion of the sale, the vice president owned 32,779 shares in the company, valued at $5,900,220. This represents a 5.75% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 50,634 shares of company stock worth $9,079,891. 3.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On The Ensign Group

A number of institutional investors and hedge funds have recently made changes to their positions in ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock valued at $20,956,000 after buying an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after acquiring an additional 230 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in The Ensign Group by 65.9% during the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after purchasing an additional 213 shares in the last quarter. Amundi boosted its position in shares of The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after purchasing an additional 57,626 shares during the period. Finally, Brown Advisory Inc. boosted its position in shares of The Ensign Group by 26.1% in the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after purchasing an additional 421 shares during the period. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.